ImmunityBio gets financing from Patrick Soon-Shiong’s Nant


The biotech company is developing therapies and vaccines that aim to bolster the natural immune system to defeat cancers and infectious diseases.

Previous Local medical device company inks five new international distribution agreements
Next Philadelphia-area home sales plummet to lowest level since 2015 as market cooldown accelerates